Potential target to treat patients with deadly lung disease identified
August 24th, 2009 - 5:53 pm ICT by ANILondon, Aug 24 (ANI): Researchers at the University of Michigan have discovered a potential target that could help treat patients with idiopathic pulmonary fibrosis, a deadly lung disease.
They found that targeting of a novel gene utilizing genetic and pharmacologic strategies was successful in treating pulmonary fibrosis in mice and will be developed for future testing in humans.
The treatments attack an oxidant-generating enzyme, NOX4, that researchers discovered is involved in the fibrotic process - which involves scar-like tissue formation in an organ such as the lung.
“We’ve identified the target. We know the enemy now. This is the first study that shows pulmonary fibrosis is driven by this NOX4 enzyme,” said Subramaniam Pennathur, M.D., assistant professor of internal medicine/nephrology.
“But what’s really significant is this discovery may have relevance to fibrosis in other organ systems, not just the lung,” Pennathur added.
Pennathur said that those suffering from common cardiac or kidney diseases, which often involve fibrosis, also may benefit from treatments stemming from this research.
The discovery was made in the University of Michigan lab of Victor J. Thannickal, M.D.
Thannickal said the study points to a very viable treatment strategy for idiopathic pulmonary fibrosis, and researchers saw success both in mouse models of lung fibrosis and in fibrogenic cells isolated from lungs of patients with Idiopathic Pulmonary Fibrosis.
“It remains to be seen if fibrosis is reversible. But therapeutic targeting of this pathway this may allow us to halt the progression of fibrosis and preserve lung function,” he said.
The findings will be published in the September issue of the journal Nature Medicine. (ANI)
- Smoking may increase risk for lung disease - Mar 10, 2011
- New therapeutic target for asthma, other lung disorders identified - Apr 18, 2011
- New way to halt lung inflammation in animal models discovered - Jan 15, 2011
- New tool to predict killer syndrome in lung transplant patients - Dec 31, 2010
- Viral infection unlikely to advance deadly lung disease - Feb 27, 2011
- New study on how liver disease develops upends previous assumptions - Dec 21, 2010
- Enzyme essential for healthy lung development discovered - Mar 30, 2011
- Novel drug may benefit cystic fibrosis patients - Dec 18, 2010
- Protein shows promise in treating smoker's diseases - Jan 16, 2012
- Healthy liver-cell transplants may help treat genetic liver-lung disorder - Apr 23, 2011
- Cigarette smoke may cause inflammation through a new chemical pathway - Sep 03, 2010
- New therapeutic target for controlling dangerous inflammation in lungs - Jan 05, 2011
- Scientists identify new antiviral defense - Jun 16, 2010
- Study reveals new warning signs that may predict kidney transplant failure - Sep 03, 2010
- Key protein behind pulmonary arterial hypertension identified - Oct 26, 2009
Tags: assistant professor, deadly lung disease, internal medicine, journal nature medicine, kidney diseases, lung fibrosis, lung function, mouse models, nephrology, novel gene, organ systems, pharmacologic strategies, pulmonary fibrosis, scar, september issue, subramaniam, target, tissue formation, treatment strategy, viable treatment
